ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,559, issued on Nov. 18, was assigned to ToolGen Inc. (Seoul, South Korea).
"Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cells" was invented by Jin-Soo Kim (Seoul, South Korea), Seung Woo Cho (Seoul, South Korea) and Sojung Kim (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to targeted genome editing in eukaryotic cells or organisms. More particularly, the present disclosure provides for Cas9/RNA complexes that may induce modifications in target endogenous nucleic acid sequences in nucleuses of eukaryotic cells. The Cas9/RNA com...